Abiopharma

🔍 Kauffman Michael (Director)

Company: Verastem, Inc. (VSTM)

Report Date: 2026-01-06

Detailed Transactions and Holdings:

• Acquired 200,000 shares of Stock Option (right to buy) at $6.88 per share (Derivative)
  Date: 2026-01-06 | Code: A | Expires: 2036-01-06 | equity_swap_involved: 0 | shares_owned_after: 200,000.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: The stock option vests 33.33% of the shares on the first anniversary of January 6, 2026 (the "Grant Date"), and an additional 8.33% will vest at the end of each successive three-month period following the first anniversary of the Grant Date until the third anniversary of the Grant Date (with the number of shares vesting on each vesting date rounded down to the nearest whole share, except with respect to the final vesting date on which all remaining unvested shares shall vest) provided that the Reporting Person continues to serve as an employee of or other service provider to the Issuer on each such vesting date.